Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

UCB Takes Back EU Try With Vimpat

Related Content

UCB Trims Down With SHAPE Program

Aug 28 2008

UCB’s Keppra XR Wins FDA Approval

Sep 15 2008

UCB’s Vimpat Falters In Diabetic Pain

Jul 29 2008

CHMP Recommends Three Approvals And Two Label Expansions, Makes One Denial

Jun 27 2008

Additional Topics

BioPharmaceutical

More from Archive

More from Pink Sheet

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window